Agilent Technologies (A) 57.55 $A
TRADE NEWS: Agilent Technologies' Next-Generation UHPLC System Sets New Benchmark in Laboratory Efficiency
Business Wire - Mon Sep 22, 7:00PM CDT
Agilent Technologies Inc. (NYSE:A) today introduced the 1290 Infinity II LC System, its new flagship instrument in the powerful 1200 Infinity Series LC portfolio. The system enables operators, scientists and laboratory managers to reach new levels of laboratory efficiency with the instrument's exceptional analytical quality, ease of use and ability to seamlessly integrate into any laboratory.
Sigma-Aldrich Hits High On Sale To Germany's Merck
at Investor's Business Daily - Mon Sep 22, 10:30AM CDT
Shares of Sigma-Aldrich (SIAL), a major provider of chemicals and other products for the life-science industry, jumped more than 34% to an all-time high near 138 in the stock market today after German drugmaker Merck KGaA announced it's buying the...
Agilent announces partial redemption of outstanding USD500m senior notes due 2017
M2 - Mon Sep 22, 8:00AM CDT
Agilent Technologies Inc (NYSE:A), a chemical analysis, life sciences, diagnostics, electronics and communications company, declared on Saturday the redemption of its outstanding USD500m 6.50% senior notes due November 2017, on 20 October 2014.
Life Sciences Tools and Services Equities Technical Data - PerkinElmer, Agilent Technologies, Bruker, Sequenom, and Illumina
PR Newswire - Mon Sep 22, 7:50AM CDT
The US markets on Friday, September 19, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,279.74, up 0.08% and the NASDAQ Composite closed at 4,579.79, down 0.30%. The S&P 500 finished the session 0.05% lower at 2,010.40. During the trading session, six out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day at 751.48, up 0.10%, with the index gaining 6.95% in the previous three months. Investor-Edge has initiated coverage on the following equities: PerkinElmer Inc. (NYSE: PKI), Agilent Technologies Inc. (NYSE: A), Bruker Corporation (NASDAQ: BRKR), Sequenom Inc. (NASDAQ: SQNM), and Illumina Inc. (NASDAQ: ILMN). Free research on these five companies can be accessed at:
Agilent Technologies calls for partial redemption of outstanding senior notes on 20 October 2014
M2 - Mon Sep 22, 6:48AM CDT
Life sciences company Agilent Technologies (NYSE:A) said on Friday that it will redeem USD500m of USD600m outstanding 6.50% senior notes due November 2017.
Research and Markets: Global PCR Technologies Global Market 2014-2020
Business Wire - Mon Sep 22, 3:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rb5tts/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering.
Global PCR Technologies Global Market 2014-2020
M2 - Mon Sep 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4kvrrv/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering. Some of the key players in the PCR market are Abbott Laboratories, Affymetrix, inc., Takara bio, Agilent Technologies, Beckman Coulter Inc., Quanta biosciences, Bio-Rad, Becton, Dickinson and Co., GE Healthcare, Sigma-Aldrich Corp., and Roche. Polymerase chain reaction (PCR) is a gene amplification technique that amplifies a single or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence. PCR plays a crucial role in understanding the genetic diseases and is also used in the characterization and detection of infectious disease organisms in diseases like Lyme disease, AIDS, middle ear infection and tuberculosis. PCR is an indispensable technique in Biotechnology, drug discovery and clinical diagnostics and it's key applications include DNA sequencing, Forensic science, Genotyping, Bioinformatics, gene expression, genetic mapping and DNA cloning. PCR products market includes Reagents, consumables, instruments, software and services. Some of the key techniques available in market are Standard/basic PCR, Real-time/Q-PCR, Digital PCR (dPCR), Reverse transcriptase PCR, Assembly PCR, Inverse PCR, Nested PCR, Multiplex PCR, Hot start PCR and touchdown PCR Among the various techniques, Q-PCR appears to be the fastest growing in PCR market followed by Reverse-Transcription PCR (RT-PCR) and Assembly. Based on the classification by products/tools, PCR Reagents is expected to be fastest growing PCR market followed by PCR Consumables and Machines. The global PCR market is projected to grow at a healthy rate. North America would account for the largest market share followed by Europe and Asia-pacific. Increasing number of patients suffering from Infectious diseases, Cancers and positive investments in gene therapy and human genome project are further driving the growth of the PCR market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 PCR Market by Types 5 PCR Market by Application 6 PCR Market by Technology 7 Regional Market Analysis 8 Company Developments 9 Major Company Profiles - Abbott Laboratories - Becton, Dickinson And Co. - Bio-Rad - Ge Healthcare - Kapa Biosystems - Maxim Biotech - Promega Corp. - Quanta Biosciences Inc. - Roche - Sigma-Aldrich Corp. - Takara Bio - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/4k...chnologies
Agilent Technologies Calls for Partial Redemption of Outstanding 6.5 Percent Senior Notes Due November 2017
Business Wire - Fri Sep 19, 3:05PM CDT
Agilent Technologies Inc. (NYSE:A) today announced it will redeem $500 million of $600 million outstanding 6.50 percent senior notes due November 2017 on Oct. 20, 2014, the redemption date. This decision is consistent with Agilent's intention to resize its debt portfolio in connection with the expected spinoff of Keysight Technologies.
Charles Dockendorff to Join Keysight Technologies Board of Directors
Business Wire - Fri Sep 19, 10:00AM CDT
Keysight Technologies, Inc., the spinoff electronic measurement company of Agilent Technologies, today announced plans to appoint Charles J. Dockendorff to its board of directors.
How Will Agilent Technologies (A) Stock Be Affected By Its CEO Transition?
at The Street - Thu Sep 18, 11:01AM CDT
Agilent Technologies (A) announced that Mike McMullen will take over as CEO from William Sullivan next March.
Agilent Board Backs Keysight Spinoff, to Pay Stock Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 8:40AM CDT
The board of directors of Agilent (A) has consented to the spinoff of its electronic measurement subsidiary Keysight and that that Keysight's outstanding common stock would be distributed to Agilent's shareholders as a special dividend distribution.
Agilent Technologies Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Wed Sep 17, 5:12PM CDT
Agilent Technologies (NYSE:A) traded in a range yesterday that spanned from a low of $57.92 to a high of $58.99. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $58.63 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for Agilent Technologies to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Wed Sep 17, 5:11PM CDT
Agilent Technologies (NYSE:A) traded in a range yesterday that spanned from a low of $57.92 to a high of $58.99. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $58.63 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Agilent Technologies Board of Directors Approves Separation of Keysight, Declares Special Dividend Distribution of Keysight Stock
Business Wire - Wed Sep 17, 3:58PM CDT
Agilent Technologies Inc. (NYSE: A) announced today that its board of directors has approved the separation of its electronic measurement subsidiary, Keysight Technologies Inc., and declared a special dividend distribution of all outstanding shares of Keysight's common stock to Agilent's shareholders.
Agilent Technologies Creates New Group for Services and Consumables
Business Wire - Wed Sep 17, 3:56PM CDT
Agilent Technologies Inc. (NYSE: A) today announced it has created a new services and consumables organization, the Agilent CrossLab Group, and named Mark Doak group president, effectively immediately. Doak has been senior vice president and general manager of the Services and Support Division.
Agilent Technologies Announces CEO Transition: Mike McMullen to Succeed Bill Sullivan in March 2015
Business Wire - Wed Sep 17, 3:54PM CDT
Agilent Technologies Inc. (NYSE:A) today announced that Mike McMullen, senior vice president, Agilent, and president of the company's Chemical Analysis Group (CAG), will succeed William (Bill) Sullivan as CEO on March 18, 2015. Sullivan will remain as an advisor through the end of the company's fiscal year, Oct. 31, 2015, when he will retire.
World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com
PRWeb - Wed Sep 17, 1:01PM CDT
The in vitro diagnostics (IVD) marketplace is a subset of the total medical technology market, focusing on molecular diagnostics for conditions such as infectious diseases, sexually-transmitted diseases, cancer, chronic diseases, and genetic testing. The IVD market value is projected to be worth around USD 70 billion by the end of 2017. The major drivers of the market's growth include the shift to point-of-care testing; need for speed, which is evidenced by the explosion for raid and minimally-invasive diagnostic tools; demand from emerging markets; and ageing population in a lot of countries. Roche Diagnostics, Siemens Healthcare, Abbot Laboratories, Agilent Technologies, diaDexus, among others, are the prominent players in the market.
Global Bioinformatics Market Outlook 2019
M2 - Wed Sep 17, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xtd5rk/global) has announced the addition of the "Global Bioinformatics Market Outlook 2019" report to their offering. The global bioinformatics market reached the mark of around US$ 3.7 Billion in 2013 with the anticipation of its growth at a CAGR of around 19% during 2015-2019 The report is an outcome of an in-depth research and comprehensive analysis of global developments and opportunities listed in the section of the bioinformatics trends. The bioinformatics market essentially is divided into 3 sections for a categorical study of the industry viz. by segment, by application and by region. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. Accordingly, the report provides a comprehensive analysis of each of these segments coupled with the information on key software and databases popular in the industry. In the application area of the bioinformatics industry, the report covers various aspects of the global bioinformatics market, giving detailed analysis of its various applications, including genomics, proteomics, transcriptomics, cheminformatics, metabolomics and molecular phylogenetics, covering the sizes of the bioinformatics market for each of these application areas till 2019. The report also offers a geographical picture of the bioinformatics sector in four regions viz. North America, Europe, Asia-Pacific and Latin America. Additionally, through country level analysis, the report portrays the bioinformatics market in major countries like US, UK, South Korea, India etc., to understand their individual market growth and future directions. A competitive analysis in the report has been done with an assortment of all the major bioinformatics players that have been active in the research and development of bioinformatics products and services. It encloses the overview, key financials and strategic initiatives by the players. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture into this industry and facilitates them to devise strategies, while going for an investment/partnership in the global bioinformatics market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Key Industry Trends and Drivers 4. Bioinformatics Market Outlook to 2019 5. Country Level Analysis 6. Commercialized Products and Services 7. Key Players - Biodiscovery, Inc. - Geneva Bioinformatics (Genebio) SA - Kinexus Bioinformatics Corporation - Accelrys, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - CLC Bio A/S - Genologics Life Sciences Software, Inc - ID Business Solutions Ltd - Illumina Inc. - Life Technologies Corporation - NonLinear Dynamics Ltd. For more information visit http://www.researchandmarkets.com/research/xtd5rk/global
Global Calibration Services Market
PR Newswire - Tue Sep 16, 4:13PM CDT
This report analyzes the worldwide markets for Calibration Services in US$ Thousands by the following Parameters of Calibration: Mechanical Calibration Services, Electrical Calibration Services, Physical/Dimensional Calibration Services, and Thermodynamic Calibration Services. The End-Use Sectors also analyzed in the report include Electronic Manufacturing, Communication, Aerospace & Defence, Industrial & Automotive, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 148 companies including many key and niche players such as -
Research and Markets: Global Companion Diagnostics Market 2014-2019: Roche Diagnostics, Abbott Laboratories, Agilent Technologies, QIAGEN N.V. & Thermo Fisher Scientific Dominate with 86% Market Share
Business Wire - Tue Sep 16, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rcg9gj/companion) has announced the addition of the "Companion Diagnostics Market byTechnology, Application , & by End-user - Global Trends & Forecasts to 2019" report to their offering.
TRADE NEWS: Agilent Technologies' Next-Generation UHPLC System Sets New Benchmark in Laboratory Efficiency
Business Wire - Mon Sep 22, 7:00PM CDT
Agilent Technologies Inc. (NYSE:A) today introduced the 1290 Infinity II LC System, its new flagship instrument in the powerful 1200 Infinity Series LC portfolio. The system enables operators, scientists and laboratory managers to reach new levels of laboratory efficiency with the instrument's exceptional analytical quality, ease of use and ability to seamlessly integrate into any laboratory.
Sigma-Aldrich Hits High On Sale To Germany's Merck
at Investor's Business Daily - Mon Sep 22, 10:30AM CDT
Shares of Sigma-Aldrich (SIAL), a major provider of chemicals and other products for the life-science industry, jumped more than 34% to an all-time high near 138 in the stock market today after German drugmaker Merck KGaA announced it's buying the...
Agilent announces partial redemption of outstanding USD500m senior notes due 2017
M2 - Mon Sep 22, 8:00AM CDT
Agilent Technologies Inc (NYSE:A), a chemical analysis, life sciences, diagnostics, electronics and communications company, declared on Saturday the redemption of its outstanding USD500m 6.50% senior notes due November 2017, on 20 October 2014.
Life Sciences Tools and Services Equities Technical Data - PerkinElmer, Agilent Technologies, Bruker, Sequenom, and Illumina
PR Newswire - Mon Sep 22, 7:50AM CDT
The US markets on Friday, September 19, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,279.74, up 0.08% and the NASDAQ Composite closed at 4,579.79, down 0.30%. The S&P 500 finished the session 0.05% lower at 2,010.40. During the trading session, six out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index ended the day at 751.48, up 0.10%, with the index gaining 6.95% in the previous three months. Investor-Edge has initiated coverage on the following equities: PerkinElmer Inc. (NYSE: PKI), Agilent Technologies Inc. (NYSE: A), Bruker Corporation (NASDAQ: BRKR), Sequenom Inc. (NASDAQ: SQNM), and Illumina Inc. (NASDAQ: ILMN). Free research on these five companies can be accessed at:
Agilent Technologies calls for partial redemption of outstanding senior notes on 20 October 2014
M2 - Mon Sep 22, 6:48AM CDT
Life sciences company Agilent Technologies (NYSE:A) said on Friday that it will redeem USD500m of USD600m outstanding 6.50% senior notes due November 2017.
Research and Markets: Global PCR Technologies Global Market 2014-2020
Business Wire - Mon Sep 22, 3:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rb5tts/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering.
Global PCR Technologies Global Market 2014-2020
M2 - Mon Sep 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4kvrrv/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering. Some of the key players in the PCR market are Abbott Laboratories, Affymetrix, inc., Takara bio, Agilent Technologies, Beckman Coulter Inc., Quanta biosciences, Bio-Rad, Becton, Dickinson and Co., GE Healthcare, Sigma-Aldrich Corp., and Roche. Polymerase chain reaction (PCR) is a gene amplification technique that amplifies a single or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence. PCR plays a crucial role in understanding the genetic diseases and is also used in the characterization and detection of infectious disease organisms in diseases like Lyme disease, AIDS, middle ear infection and tuberculosis. PCR is an indispensable technique in Biotechnology, drug discovery and clinical diagnostics and it's key applications include DNA sequencing, Forensic science, Genotyping, Bioinformatics, gene expression, genetic mapping and DNA cloning. PCR products market includes Reagents, consumables, instruments, software and services. Some of the key techniques available in market are Standard/basic PCR, Real-time/Q-PCR, Digital PCR (dPCR), Reverse transcriptase PCR, Assembly PCR, Inverse PCR, Nested PCR, Multiplex PCR, Hot start PCR and touchdown PCR Among the various techniques, Q-PCR appears to be the fastest growing in PCR market followed by Reverse-Transcription PCR (RT-PCR) and Assembly. Based on the classification by products/tools, PCR Reagents is expected to be fastest growing PCR market followed by PCR Consumables and Machines. The global PCR market is projected to grow at a healthy rate. North America would account for the largest market share followed by Europe and Asia-pacific. Increasing number of patients suffering from Infectious diseases, Cancers and positive investments in gene therapy and human genome project are further driving the growth of the PCR market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 PCR Market by Types 5 PCR Market by Application 6 PCR Market by Technology 7 Regional Market Analysis 8 Company Developments 9 Major Company Profiles - Abbott Laboratories - Becton, Dickinson And Co. - Bio-Rad - Ge Healthcare - Kapa Biosystems - Maxim Biotech - Promega Corp. - Quanta Biosciences Inc. - Roche - Sigma-Aldrich Corp. - Takara Bio - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/4k...chnologies
Agilent Technologies Calls for Partial Redemption of Outstanding 6.5 Percent Senior Notes Due November 2017
Business Wire - Fri Sep 19, 3:05PM CDT
Agilent Technologies Inc. (NYSE:A) today announced it will redeem $500 million of $600 million outstanding 6.50 percent senior notes due November 2017 on Oct. 20, 2014, the redemption date. This decision is consistent with Agilent's intention to resize its debt portfolio in connection with the expected spinoff of Keysight Technologies.
Charles Dockendorff to Join Keysight Technologies Board of Directors
Business Wire - Fri Sep 19, 10:00AM CDT
Keysight Technologies, Inc., the spinoff electronic measurement company of Agilent Technologies, today announced plans to appoint Charles J. Dockendorff to its board of directors.
How Will Agilent Technologies (A) Stock Be Affected By Its CEO Transition?
at The Street - Thu Sep 18, 11:01AM CDT
Agilent Technologies (A) announced that Mike McMullen will take over as CEO from William Sullivan next March.
Agilent Board Backs Keysight Spinoff, to Pay Stock Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 18, 8:40AM CDT
The board of directors of Agilent (A) has consented to the spinoff of its electronic measurement subsidiary Keysight and that that Keysight's outstanding common stock would be distributed to Agilent's shareholders as a special dividend distribution.
Agilent Technologies Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Wed Sep 17, 5:12PM CDT
Agilent Technologies (NYSE:A) traded in a range yesterday that spanned from a low of $57.92 to a high of $58.99. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $58.63 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for Agilent Technologies to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Wed Sep 17, 5:11PM CDT
Agilent Technologies (NYSE:A) traded in a range yesterday that spanned from a low of $57.92 to a high of $58.99. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $58.63 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Agilent Technologies Board of Directors Approves Separation of Keysight, Declares Special Dividend Distribution of Keysight Stock
Business Wire - Wed Sep 17, 3:58PM CDT
Agilent Technologies Inc. (NYSE: A) announced today that its board of directors has approved the separation of its electronic measurement subsidiary, Keysight Technologies Inc., and declared a special dividend distribution of all outstanding shares of Keysight's common stock to Agilent's shareholders.
Agilent Technologies Creates New Group for Services and Consumables
Business Wire - Wed Sep 17, 3:56PM CDT
Agilent Technologies Inc. (NYSE: A) today announced it has created a new services and consumables organization, the Agilent CrossLab Group, and named Mark Doak group president, effectively immediately. Doak has been senior vice president and general manager of the Services and Support Division.
Agilent Technologies Announces CEO Transition: Mike McMullen to Succeed Bill Sullivan in March 2015
Business Wire - Wed Sep 17, 3:54PM CDT
Agilent Technologies Inc. (NYSE:A) today announced that Mike McMullen, senior vice president, Agilent, and president of the company's Chemical Analysis Group (CAG), will succeed William (Bill) Sullivan as CEO on March 18, 2015. Sullivan will remain as an advisor through the end of the company's fiscal year, Oct. 31, 2015, when he will retire.
World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com
PRWeb - Wed Sep 17, 1:01PM CDT
The in vitro diagnostics (IVD) marketplace is a subset of the total medical technology market, focusing on molecular diagnostics for conditions such as infectious diseases, sexually-transmitted diseases, cancer, chronic diseases, and genetic testing. The IVD market value is projected to be worth around USD 70 billion by the end of 2017. The major drivers of the market's growth include the shift to point-of-care testing; need for speed, which is evidenced by the explosion for raid and minimally-invasive diagnostic tools; demand from emerging markets; and ageing population in a lot of countries. Roche Diagnostics, Siemens Healthcare, Abbot Laboratories, Agilent Technologies, diaDexus, among others, are the prominent players in the market.
Global Bioinformatics Market Outlook 2019
M2 - Wed Sep 17, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xtd5rk/global) has announced the addition of the "Global Bioinformatics Market Outlook 2019" report to their offering. The global bioinformatics market reached the mark of around US$ 3.7 Billion in 2013 with the anticipation of its growth at a CAGR of around 19% during 2015-2019 The report is an outcome of an in-depth research and comprehensive analysis of global developments and opportunities listed in the section of the bioinformatics trends. The bioinformatics market essentially is divided into 3 sections for a categorical study of the industry viz. by segment, by application and by region. By segment, the bioinformatics market is divided into data analysis and software, tools and database services, and IT Infrastructure. Accordingly, the report provides a comprehensive analysis of each of these segments coupled with the information on key software and databases popular in the industry. In the application area of the bioinformatics industry, the report covers various aspects of the global bioinformatics market, giving detailed analysis of its various applications, including genomics, proteomics, transcriptomics, cheminformatics, metabolomics and molecular phylogenetics, covering the sizes of the bioinformatics market for each of these application areas till 2019. The report also offers a geographical picture of the bioinformatics sector in four regions viz. North America, Europe, Asia-Pacific and Latin America. Additionally, through country level analysis, the report portrays the bioinformatics market in major countries like US, UK, South Korea, India etc., to understand their individual market growth and future directions. A competitive analysis in the report has been done with an assortment of all the major bioinformatics players that have been active in the research and development of bioinformatics products and services. It encloses the overview, key financials and strategic initiatives by the players. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture into this industry and facilitates them to devise strategies, while going for an investment/partnership in the global bioinformatics market. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Key Industry Trends and Drivers 4. Bioinformatics Market Outlook to 2019 5. Country Level Analysis 6. Commercialized Products and Services 7. Key Players - Biodiscovery, Inc. - Geneva Bioinformatics (Genebio) SA - Kinexus Bioinformatics Corporation - Accelrys, Inc. - Affymetrix, Inc. - Agilent Technologies, Inc. - CLC Bio A/S - Genologics Life Sciences Software, Inc - ID Business Solutions Ltd - Illumina Inc. - Life Technologies Corporation - NonLinear Dynamics Ltd. For more information visit http://www.researchandmarkets.com/research/xtd5rk/global
Global Calibration Services Market
PR Newswire - Tue Sep 16, 4:13PM CDT
This report analyzes the worldwide markets for Calibration Services in US$ Thousands by the following Parameters of Calibration: Mechanical Calibration Services, Electrical Calibration Services, Physical/Dimensional Calibration Services, and Thermodynamic Calibration Services. The End-Use Sectors also analyzed in the report include Electronic Manufacturing, Communication, Aerospace & Defence, Industrial & Automotive, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 148 companies including many key and niche players such as -
Research and Markets: Global Companion Diagnostics Market 2014-2019: Roche Diagnostics, Abbott Laboratories, Agilent Technologies, QIAGEN N.V. & Thermo Fisher Scientific Dominate with 86% Market Share
Business Wire - Tue Sep 16, 10:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rcg9gj/companion) has announced the addition of the "Companion Diagnostics Market byTechnology, Application , & by End-user - Global Trends & Forecasts to 2019" report to their offering.
